
Laurel Lee Periodic Transaction Report
Filed Jan 7, 2025 · House Clerk · 2 transactions
U.S. Representative · R · FL-15 · All trades by Laurel Lee
On January 7, 2025, Rep. Laurel Lee (R-FL-15) filed a periodic transaction report with the House Clerk disclosing 2 transactions (1 purchase, 1 sale) dated Nov 25, 2024 through Nov 29, 2024.
The filing covers 2 tickers, including $HURA, $WBD.
Reported amount ranges sum to $2K–$30K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 43 days.
2 transactions were reported under a spouse, dependent child, or joint account rather than the member directly.
Source document: House Clerk filing 20026513
Sample · the intelligence layer
Laurel Lee · Bought $HURA · Nov 25 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Laurel Lee
Get an email the moment Laurel Lee files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | HURAHURATuHURA Biosciences, Inc. - Common Stock | TuHURA Biosciences, Inc. - Common Stock (HURA) | buy | Spouse | $1K–$15K | 43d |
| Nov 29, 2024 | WBDWBDWarner Bros. Discovery, Inc. - Series A Common Stock | Warner Bros. Discovery, Inc. - Series A Common Stock (WBD) | sell | Spouse | $1K–$15K | 39d |
Other recent filings by Laurel Lee
- PTR filed Jul 19, 20266 trades · NOK, BAC, GE
- PTR filed Aug 11, 20252 trades · BABA, WBD
- PTR filed Aug 9, 20251 trade · HURA
- PTR filed Jun 22, 20251 trade · NVO
- PTR filed Nov 21, 20244 trades · AAPL, GEV, HURA, PFE
- PTR filed Sep 14, 20242 trades · AAPL, JPM
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →